Cargando…

An integrated bioinformatics analysis to investigate the targets of miR-133a-1 in breast cancer

BACKGROUND: The microRNA (miRNA) miR-133a-1 has been identified as a tumor suppressor in breast cancer. However, the underlying mechanisms of miR-133a-1 in breast cancer have not been fully elucidated. This study aimed to explore the targets of miR-133a-1 in breast cancer using an integrated bioinfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Yanchun, Tang, Hao, Luo, Zhiguo, Tan, Wenlong, Chen, Lin, Du, Yiqun, Tao, Zhonghua, Huang, Mingzhu, Li, Wenhua, Cao, Jun, Wang, Leiping, Li, Ting, Liu, Xin, Lv, Fangfang, Liu, Xiaojian, Zhang, Jian, Zheng, Lei, Hu, Xichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799015/ https://www.ncbi.nlm.nih.gov/pubmed/35116451 http://dx.doi.org/10.21037/tcr-20-2681

Ejemplares similares

miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2
por: Zhao, Mingchuan, et al.
Publicado: (2020)

PDGFD induces ibrutinib resistance of diffuse large B-cell lymphoma through activation of EGFR
por: Jin, Jia, et al.
Publicado: (2020)

Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer
por: Li, Ting, et al.
Publicado: (2021)

Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study
por: Gao, Li, et al.
Publicado: (2017)

Utility of miR-133a-3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta-analysis and bioinformatics
por: Liang, Hai-Wei, et al.
Publicado: (2018)

Smad8 Is Increased in Duchenne Muscular Dystrophy and Suppresses miR-1, miR-133a, and miR-133b
por: Lopez, Michael A., et al.
Publicado: (2022)

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
por: Koutsoulidou, Andrie, et al.
Publicado: (2011)

miR-133: A Suppressor of Cardiac Remodeling?
por: Li, Ning, et al.
Publicado: (2018)

Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s disease
por: Chen, Qihua, et al.
Publicado: (2021)

Age-Related Exosomal and Endogenous Expression Patterns of miR-1, miR-133a, miR-133b, and miR-206 in Skeletal Muscles
por: Mytidou, Chrystalla, et al.
Publicado: (2021)

[Corrigendum] DNA methylation is involved in the aberrant expression of miR‑133b in colorectal cancer cells
por: Lv, Lv, et al.
Publicado: (2023)

Guanidinoacetic Acid Attenuates Adipogenesis through Regulation of miR-133a in Sheep
por: Zhao, Jia-Min, et al.
Publicado: (2023)

Obesity-induced inflammatory miR-133a mediates apoptosis of granulosa cells and causes abnormal folliculogenesis: Role of miR-133a in folliculogenesis
por: Chen, Ruizhi, et al.
Publicado: (2023)

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer
por: Zhang, Jian, et al.
Publicado: (2017)

Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study
por: Zhang, Jian, et al.
Publicado: (2022)

Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction
por: Peng, Liu, et al.
Publicado: (2014)

miR-133a Regulates Adipocyte Browning In Vivo
por: Liu, Weiyi, et al.
Publicado: (2013)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA
por: Kang, Min, et al.
Publicado: (2020)

Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis
por: Lin, Ying, et al.
Publicado: (2020)

Emerging roles of MiR-133a in human cancers
por: Hua, Yu-Ting, et al.
Publicado: (2021)

Phase II Study of Pseudomonas aeruginosa-Mannose-Sensitive Hemagglutinin in Combination with Capecitabine for Her-2–Negative Metastatic Breast Cancer Pretreated with Anthracycline and Taxane
por: Lv, Fangfang, et al.
Publicado: (2015)

TAp63 suppress metastasis via miR-133b in colon cancer cells
por: Lin, C W, et al.
Publicado: (2014)

Role of miR-1 and miR-133a in myocardial ischemic postconditioning
por: He, Bin, et al.
Publicado: (2011)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
por: Coccia, Elena, et al.
Publicado: (2020)

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial
por: Wang, Leiping, et al.
Publicado: (2021)

miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer
por: Wang, Xiao, et al.
Publicado: (2017)

The Clinicopathological Significance of miR-133a in Colorectal Cancer
por: Wan, Timothy Ming-Hun, et al.
Publicado: (2014)

miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1
por: Li, Chuntao, et al.
Publicado: (2016)

Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease
por: Zhang, Xiong, et al.
Publicado: (2017)

Transgenic overexpression of miR-133a in skeletal muscle
por: Deng, Zhongliang, et al.
Publicado: (2011)

miR-133a function in the pathogenesis of dedifferentiated liposarcoma
por: Yu, Peter Y., et al.
Publicado: (2018)

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial
por: Zhao, Yannan, et al.
Publicado: (2018)

A heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundance
por: Ohanian, Monique, et al.
Publicado: (2013)

Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion
por: Wu, Zheng-sheng, et al.
Publicado: (2012)

Response to comment on ‘TAp63 suppress metastasis via miR-133b in colon cancer cells'
por: Lin, C W, et al.
Publicado: (2014)

miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer
por: Karatas, Omer Faruk, et al.
Publicado: (2014)

Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study
por: Ji, Dongmei, et al.
Publicado: (2016)

The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism
por: Chen, Yao-ping, et al.
Publicado: (2016)

Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome
por: Šatrauskienė, Agnė, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_22f424sbh027mktp0ccfcejfjk